Hyperthyroidism Diagnosis
Hyperthyroidism Diagnosis
The diagnosis of an overactive thyroid is one of the most straightforward in endocrinology, and that is precisely why the important part is not the first test but the second question. A suppressed thyroid stimulating hormone with raised free hormone levels establishes what the gland is doing within a day. What follows is the part that decides treatment: is the gland producing too much hormone, or is it leaking hormone it had already stored because it is inflamed? The two look identical on the blood tests and can feel identical to the patient, but drugs that block production are the right answer to the first and the wrong answer to the second. Antibodies, an ultrasound and an uptake scan are what separate them. This page sets out each test, what it answers, and — most usefully — the point in the pathway at which each one earns its place.
The blood tests: what the gland is doing
Three measurements, taken together, are what establish an overactive thyroid:
- TSH (thyroid stimulating hormone) — made by the pituitary gland to tell the thyroid how much hormone to produce. It is the most sensitive single indicator, and in an overactive thyroid it is suppressed, usually to a level that is very low or unmeasurable. The pituitary is doing its job correctly: it is trying to switch the gland off, and the gland is not listening.
- Free T4 — the main circulating hormone, and the one most treatments are monitored against. It is raised in the typical picture.
- Free T3 — the active form of the hormone, and the one that does most of the work in the tissues. It matters because there is a pattern — T3 toxicosis — in which T3 is clearly raised while T4 is still within the normal range. Checking T4 alone would miss those patients.
One pattern deserves its own note. A suppressed TSH with normal free T4 and free T3 is called subclinical hyperthyroidism. It is not a false alarm, but it is not the same problem either: it may progress, it may matter particularly for an older patient or for the heart and bones, and it may need repeating rather than treating at once. It is worth asking exactly which of these three numbers was abnormal, because "your thyroid is overactive" describes several different situations.
The antibodies: naming Graves’ disease
Antibodies are what make the diagnosis specific, and there are two groups worth knowing:
- TSH receptor antibodies (TRAb) — the antibody that causes Graves’ disease. It binds to the receptor that normally answers TSH and switches the gland on continuously, which is why the gland produces hormone whether or not the body needs it. A positive result names the cause, and it also carries information about the eyes, because the same antibody is involved in Graves’ eye disease.
- Anti-thyroid peroxidase and anti-thyroglobulin antibodies — markers of an autoimmune thyroid background. They are common in Graves’ disease, but they are also found in people whose thyroid is not overactive, so they support the picture rather than define it.
- Why antibodies are worth measuring rather than assuming — Graves’ disease, toxic multinodular goitre and thyroiditis lead to different treatments, and the antibody is the quickest way to point towards one of them. In pregnancy it also matters for the baby, so it is checked for a specific reason.
The ultrasound: describing the gland itself
Ultrasound does not diagnose overactivity, but it describes the anatomy that explains it:
- A diffusely enlarged, evenly changed gland — the typical appearance in Graves’ disease, where the whole gland is being stimulated. Increased blood flow is part of the picture.
- A knobbly, multinodular gland — pointing towards toxic multinodular goitre, particularly in an older patient with a long-standing goitre.
- A single nodule — raising the possibility of a toxic adenoma, especially if the rest of the gland appears quiet. Ultrasound also describes whether that nodule has any features that would need assessment in their own right.
- A tender, enlarged gland with altered texture — supporting thyroiditis when the gland is painful to touch, which is a clinical finding as much as an ultrasound one.
Ultrasound also does something the blood tests cannot: it finds the nodules that may have become autonomous, and it describes whether any of them has features that deserve sampling independently of the overactivity.
The uptake scan: the test that decides
This is the investigation worth understanding properly, because it is the one that separates two groups of patients who look identical on every other test:
| Pattern on the uptake scan | What it means | What follows from it |
|---|---|---|
| Diffusely increased uptake | The whole gland is producing too much hormone — the pattern of Graves’ disease | All three treatment routes are open: antithyroid drugs, radioactive iodine, or surgery |
| Uptake concentrated in one area | A single nodule is autonomous — a toxic adenoma — and is suppressing the rest of the gland | The problem is localised, which often makes radioactive iodine or surgery the more logical route |
| Uptake in several areas | Several autonomous areas within a multinodular gland — toxic multinodular goitre | Managed by drugs, radioactive iodine or surgery, with the size and position of the goitre taken into account |
| Low or absent uptake | The gland is not overproducing — it is leaking stored hormone because of thyroiditis, or the hormone is coming from a tablet | Antithyroid drugs are the wrong treatment; the correct care is symptomatic, and the episode is usually watched through |
Two conclusions are worth holding on to. First, a low uptake is a result, not a failed test: it changes the treatment, and protects a patient from a course of drugs that would never have worked. Second, the scan is not needed in everyone — when the receptor antibody is clearly positive and the gland is diffusely enlarged, Graves’ disease is already established, and the scan is reserved for patients in whom the answer is genuinely in doubt.
The heart tracing, and the tests that prepare for treatment
A small number of additional tests do not diagnose the thyroid problem but change how it is managed:
- ECG (heart tracing) — records whether the rhythm is regular. An overactive thyroid is a recognised cause of atrial fibrillation, and in some patients the heart rhythm is the first thing found, with the thyroid discovered only because it was tested.
- Full blood count — a baseline before antithyroid drugs, which can rarely affect the white cells. It is also the reason a patient on these drugs is told to report a sore throat or fever promptly rather than to wait.
- Liver tests — a baseline before antithyroid drugs, and because an overactive thyroid can itself affect liver results.
- Calcium — relevant where surgery is being considered, because the glands that control calcium sit just behind the thyroid.
- A pregnancy test where relevant — because it changes the choice of drug and rules out radioactive iodine altogether.
What a complete assessment should produce
By the end of an adequate assessment, a patient should be able to answer four questions without hesitation:
- What is my thyroid doing? — the actual numbers: TSH, free T4 and free T3, and whether this is the typical picture or a milder, subclinical one.
- What is the cause? — Graves’ disease, an autonomous nodule, a multinodular gland, thyroiditis, an iodine load, or a hormone tablet. This is the answer that determines everything else.
- What has it done to me so far? — the heart rhythm, the eyes, weight and bone. These are what an assessment is measuring, not just the hormone level.
- What are the options, and which suits me? — drugs, radioactive iodine or surgery, each with a different time course and a different set of trade-offs, chosen with the patient rather than for them.
If the cause has not been named, the assessment is incomplete — not because the treatment cannot be started, but because it cannot be chosen properly.